200 related articles for article (PubMed ID: 24748122)
1. Interceptor effect of C60 fullerene on the in vitro action of aromatic drug molecules.
Skamrova GB; Laponogov I; Buchelnikov AS; Shckorbatov YG; Prylutska SV; Ritter U; Prylutskyy YI; Evstigneev MP
Eur Biophys J; 2014 Jul; 43(6-7):265-76. PubMed ID: 24748122
[TBL] [Abstract][Full Text] [Related]
2. Interceptor potential of C
Salo VA; Buchelnikov AS; Evstigneev MP
Eur Biophys J; 2022 Apr; 51(3):297-307. PubMed ID: 35307756
[TBL] [Abstract][Full Text] [Related]
3. Anticoronavirus Activity of Water-Soluble Pristine C
Hurmach V; Platonov M; Prylutska S; Klestova Z; Cherepanov V; Prylutskyy Y; Ritter U
Adv Exp Med Biol; 2021; 1352():159-172. PubMed ID: 35132600
[TBL] [Abstract][Full Text] [Related]
4. Does C
Borowik A; Prylutskyy Y; Kawelski Ł; Kyzyma O; Bulavin L; Ivankov O; Cherepanov V; Wyrzykowski D; Kaźmierkiewicz R; Gołuński G; Woziwodzka A; Evstigneev M; Ritter U; Piosik J
Colloids Surf B Biointerfaces; 2018 Apr; 164():134-143. PubMed ID: 29413590
[TBL] [Abstract][Full Text] [Related]
5. Complexation of C60 fullerene with aromatic drugs.
Evstigneev MP; Buchelnikov AS; Voronin DP; Rubin YV; Belous LF; Prylutskyy YI; Ritter U
Chemphyschem; 2013 Feb; 14(3):568-78. PubMed ID: 23345058
[TBL] [Abstract][Full Text] [Related]
6. The theory of interceptor-protector action of DNA binding drugs.
Evstigneev MP; Buchelnikov AS; Evstigneev VP
Prog Biophys Mol Biol; 2019 Dec; 149():131-146. PubMed ID: 30991057
[TBL] [Abstract][Full Text] [Related]
7. C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes.
Skorkina MY; Sladkova EA; Shamray EA; Cherkashina OV; Evstigneev MP; Buchelnikov AS; Prylutskyy YI; Ritter U
Eur Biophys J; 2015 Sep; 44(6):493-8. PubMed ID: 26071689
[TBL] [Abstract][Full Text] [Related]
8. Characterization of C60 fullerene complexation with antibiotic doxorubicin.
Prylutskyy YI; Evstigneev MP; Pashkova IS; Wyrzykowski D; Woziwodzka A; Gołuński G; Piosik J; Cherepanov VV; Ritter U
Phys Chem Chem Phys; 2014 Nov; 16(42):23164-72. PubMed ID: 25251969
[TBL] [Abstract][Full Text] [Related]
9. Molecular Dynamics Simulation Study of the HIV-1 Protease Inhibit ion Using Fullerene and New Fullerene Derivatives of Carbon Nanostructures.
Barzegar A; Naghizadeh E; Zakariazadeh M; Azamat J
Mini Rev Med Chem; 2017; 17(7):633-647. PubMed ID: 27292780
[TBL] [Abstract][Full Text] [Related]
10. C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
Prylutska S; Grynyuk I; Matyshevska O; Prylutskyy Y; Evstigneev M; Scharff P; Ritter U
Drugs R D; 2014 Dec; 14(4):333-40. PubMed ID: 25504158
[TBL] [Abstract][Full Text] [Related]
11. C
Melnyk MI; Ivanova IV; Dryn DO; Prylutskyy YI; Hurmach VV; Platonov M; Al Kury LT; Ritter U; Soloviev AI; Zholos AV
Nanomedicine; 2019 Jul; 19():1-11. PubMed ID: 30981819
[TBL] [Abstract][Full Text] [Related]
12. Effects intracerebral microinjection and intraperitoneal injection of [60]fullerene on brain functions differ in rats.
Yamada T; Jung DY; Sawada R; Matsuoka A; Nakaoka R; Tsuchiya T
J Nanosci Nanotechnol; 2008 Aug; 8(8):3973-80. PubMed ID: 19049160
[TBL] [Abstract][Full Text] [Related]
13. A Novel Nanoconjugate of Landomycin A with C
Bilobrov V; Sokolova V; Prylutska S; Panchuk R; Litsis O; Osetskyi V; Evstigneev M; Prylutskyy Y; Epple M; Ritter U; Rohr J
Cell Mol Bioeng; 2019 Feb; 12(1):41-51. PubMed ID: 31719898
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of cellular responses induced by stable fullerene C60 medium dispersion.
Horie M; Nishio K; Kato H; Shinohara N; Nakamura A; Fujita K; Kinugasa S; Endoh S; Yamamoto K; Yamamoto O; Niki E; Yoshida Y; Iwahashi H
J Biochem; 2010 Sep; 148(3):289-98. PubMed ID: 20576621
[TBL] [Abstract][Full Text] [Related]
15. Analysis of C60-fullerene derivatives and pristine fullerenes in environmental samples by ultrahigh performance liquid chromatography-atmospheric pressure photoionization-mass spectrometry.
Astefanei A; Núñez O; Galceran MT
J Chromatogr A; 2014 Oct; 1365():61-71. PubMed ID: 25204268
[TBL] [Abstract][Full Text] [Related]
16. Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.
Panchuk RR; Prylutska SV; Chumakl VV; Skorokhyd NR; Lehka LV; Evstigneev MP; Prylutskyy YI; Berger W; Heffeter P; Scharff P; Ritter U; Stoika RS
J Biomed Nanotechnol; 2015 Jul; 11(7):1139-52. PubMed ID: 26307837
[TBL] [Abstract][Full Text] [Related]
17. C
Grebinyk A; Grebinyk S; Prylutska S; Ritter U; Matyshevska O; Dandekar T; Frohme M
Free Radic Biol Med; 2018 Aug; 124():319-327. PubMed ID: 29940354
[TBL] [Abstract][Full Text] [Related]
18. C
Hurmach Y; Rudyk M; Prylutska S; Hurmach V; Prylutskyy YI; Ritter U; Scharff P; Skivka L
Mol Pharm; 2020 Sep; 17(9):3622-3632. PubMed ID: 32673486
[No Abstract] [Full Text] [Related]
19. Fullerene mediates proliferation and cardiomyogenic differentiation of adipose-derived stem cells via modulation of MAPK pathway and cardiac protein expression.
Hao T; Zhou J; Lü S; Yang B; Wang Y; Fang W; Jiang X; Lin Q; Li J; Wang C
Int J Nanomedicine; 2016; 11():269-83. PubMed ID: 26848263
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
Skariyachan S; Parveen A; Garka S
J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
